PANBELA THERAPEUTICS INC's ticker is PBLA and the CUSIP is 69833Q100. A total of 17 filers reported holding PANBELA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | +20.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -18.6% | 20,000 | 0.0% | 0.00% | – |
| Q3 2021 | $43,000 | -24.6% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $57,000 | -27.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $79,000 | -63.4% | 20,000 | -67.0% | 0.00% | -50.0% |
| Q4 2020 | $216,000 | – | 60,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 355,959 | $750,000 | 0.10% |
| Brand Asset Management Group, Inc. | 57,144 | $121,000 | 0.05% |
| Fieldpoint Private Securities, LLC | 62,621 | $132,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,018 | $72,000 | 0.00% |
| BUCKINGHAM STRATEGIC WEALTH, LLC | 24,927 | $53,000 | 0.00% |
| Verition Fund Management LLC | 20,000 | $42,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,958 | $29,000 | 0.00% |
| MORGAN STANLEY | 12,500 | $26,000 | 0.00% |
| BlackRock Inc. | 28,723 | $61,000 | 0.00% |